XML 93 R80.htm IDEA: XBRL DOCUMENT v3.25.2
Note 16 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Aug. 31, 2025
Aug. 31, 2024
Net (loss) income $ 1,513 $ (34,652)
Net comprehensive (loss) income 1,325 (30,492)
Comprehensive (loss) income attributable to NCI 1,814 5,051
Subsidiaries [Member]    
Revenue 18,102 18,558
Total expenses 13,311 9,851
Net (loss) income 4,791 8,707
Other comprehensive (loss) income (1,058) 1,317
Net comprehensive (loss) income 3,733 10,024
Comprehensive (loss) income attributable to NCI 1,814 5,051
Net comprehensive (loss) income attributable to NCI 1,814 5,051
Aphria Diamond [Member]    
Revenue 18,102 18,558
Total expenses 13,497 9,216
Net (loss) income 4,605 9,342
Other comprehensive (loss) income (911) 1,041
Net comprehensive (loss) income $ 3,694 $ 10,383
Non-controlling interest % 49.00% 49.00%
Comprehensive (loss) income attributable to NCI $ 1,810 $ 5,088
Net comprehensive (loss) income attributable to NCI 1,810 5,088
ColCanna S.A.S. [Member]    
Revenue 0 0
Total expenses (186) 630
Net (loss) income 186 (630)
Other comprehensive (loss) income (147) 277
Net comprehensive (loss) income $ 39 $ (353)
Non-controlling interest % 10.00% 10.00%
Comprehensive (loss) income attributable to NCI $ 4 $ (35)
Net comprehensive (loss) income attributable to NCI $ 4 (35)
Superhero Acquisition LP [Member]    
Revenue   0
Total expenses   0
Net (loss) income   0
Other comprehensive (loss) income   0
Net comprehensive (loss) income   $ 0
Non-controlling interest %   32.00%
Comprehensive (loss) income attributable to NCI   $ 0
Net comprehensive (loss) income attributable to NCI   0
CC Pharma Nordic ApS [Member]    
Revenue   0
Total expenses   5
Net (loss) income   (5)
Other comprehensive (loss) income   (1)
Net comprehensive (loss) income   $ (6)
Non-controlling interest %   25.00%
Comprehensive (loss) income attributable to NCI   $ (2)
Net comprehensive (loss) income attributable to NCI   $ (2)